Munich, Bavaria, Germany
Medical Affairs Leader for Oncology, Hematology and Immunology Inventive and pragmatic Senior Director of Business Development, with 15+ years of experience in the Life Sciences industry, combines broad scientific knowledge with strong business acumen. Successfully builds partnerships across geographies, always has the patients’ needs at heart. Develops and refines medical as well as commercial strategy. Efficiently builds stakeholder networks to support product launches. Known as energetic and empathetic team leader, thrives when faced with a challenge. Core competencies include: Stakeholder Management • Strategic Planning • Product Launches • LCM • Market Analysis • Project Management • Business Development • Contract Negotiations • Problem Solving
Tasks: - Initiate and advance external partnerships with key academic research centers within the Global Expert Centers Initiative (GECI) - Build and maintain trusted relationships with leadership at partner centers - Advance the BMS scientific strategy by collaborating extensively with stakeholders, and by matching partners’ capabilities with BMS’ strategic needs - Develop and implement a global Biobank Mapping Initiative for GECI partner sites in oncology and hematology - Act as the link between the Worldwide teams, country teams, and the sites to ensure that the mutual commitments of each partnership are consistently met - Lead the Immunology and Fibrosis (I&F) evolution of GECI Achievements: - Initiated contact to one new Global Expert Centers Initiative (GECI) site, negotiated and executed GECI Alliance Agreement - Renewed GECI Alliance Agreements with four other GECI sites in Germany - Organized and facilitated annual joint steering committee meetings between sites’ leadership and BMS senior leaders with five GECI sites in Germany, ensuring strategic alignment for research collaborations - Led and completed Biobank Mapping of 28 GECI sites in 14 countries for oncology and hematology. Disseminated results to Medical and Development teams, used data for partner identification in translational medicine projects - Drove global data generation project to analyze LAG-3 prevalence and additional biomarkers across various tumor entities - Developed strategy for global evolution of GECI from oncology and hematology into Immunology and Fibrosis, won senior leadership approval for strategy and secured budget for expansion. - Led planning and initiation of collaborative trial in ulcerative colitis with three world-leading centers - Contributed to Integrated Evidence Plan for cendakimab in I&F
Tasks: - Line manager for four Global Medical Advisors Psoriasis and in the end no Global Medical Advisor Actinic Keratosis - Ensure globally aligned launch strategies for psoriasis and AK products - Review affiliate medical affairs strategies - Co-develop publication plans and strategy with Publications Manager - Provide MSLs with supporting materials and training - Head of Global IIS Review Committee - Head of Global NIS Review Committee - Final Approver of all LEO publications (excluding only eczema) - Final Signatory on non-promotional external communications - Member of the Global Psoriasis Strategy Review Board - Member of the Global Program Team Psoriasis and AK - Member of the Global Medical Affairs Leadership Team - Member of the Global Safety Review Board Achievements: - Provided launch and medical affairs support for Enstilar® globally, now the top selling product in the LEO psoriasis portfolio - Co-led development of Enstilar® global launch strategy in “proactive management” of psoriasis with Marketing and Market Access - Developed Medical Affairs Strategy for Psoriasis incl. Publication Plan - Developed and implemented Patient Advocacy Program for Psoriasis - Improved global stakeholder engagement for KOLs - Performed global psoriasis guideline analysis - Updated Payer messaging to maintain reimbursement of price premium - Managed external stakeholders in premature closing of Phase 3 AK trial
Tasks: -Coordinate activities of the Global Scientific Advisors for Psoriasis and Actinic Keratosis -Take lead on complex, global projects -Provide scientific support to LEO affiliates on inflammatory skin diseases -Guide development of research projects and life cycle management -Conduct scientific training -Give input to publication plans and strategy -Develop target product claims -Conduct medical review of external communications -Member of the Global Portfolio Team Psoriasis and AK -Interim member of the Scientific Affairs Leadership Team -Interim member of the Commercial Portfolio Management Leadership Team Achievements: -Key contributor to Disease Area Strategy Psoriasis, defining disease opportunity profiles for R&D and BD -Key contributor to Commercial Portfolio Strategy for Psoriasis -Drove update of Publication Strategy Psoriasis -On-boarded first affiliates to participate in global non-interventional study
Tasks: -Development of Target Product Claims and scientific communication -Facilitate new product launches -Work closely with Scientific Affairs staff around the globe -Strategic partnering with interdisciplinary project teams in drug development -Assist with global publication planning -Serve as liaison between the R&D and Marketing functions Achievements: -Guided preparation and roll-out of global educational initiative “Psoriasis Academy” in Europe, Asia and the middle East -Involved in global strategy development for psoriasis and atopic dermatitis -Led the development of a global non-interventional study
Co owner and business administrator of a Danish-French, upper scale restaurant. Sold successfully after start-up.
Tasks: - Drive internal projects for the development of new offerings - Manage external collaborations to gain access to new products and services - Continuously analyze the pre-clinical market to identify emerging trends, and prepare business plans for a possible commercialization - Facilitate entry into new markets, scientifically as well as geographically, and serve as project manager for the introduction of new products - Lead the development of marketing materials for new offerings - Conduct internal trainings for new products - Manage lifecycle of offerings after launch - Co-supervise an industrial PhD student Achievements: - Established a partnership with the University of Kumamoto and Cosmo Bio Ltd. in Japan regarding mouse embryology - Managed the set-up of a gnotobiotic services facility in collaboration with Bioaster in Lyon, France - Facilitated inter-departmental technology transfer within the company, leading to significant cost reduction in operations - Supported revenue growth in India by co-organizing and presenting at local workshops, interacting with Indian key opinion leaders and distributors
Tasks: - Headed an inter-disciplinary team of eight in a matrix organization - Managed sales and marketing in Germany, from April 2011 additionally responsible for the UK and Ireland - Until end of 2010, European sales coordinator for custom mouse model generation services (with forecasting and reporting responsibilities) - Provided scientific counsel to customers - Fed back information from the field to Business Development, participated in strategy development - Represented the company at trade shows and partnering events Achievements: - Significant growth in mature markets, grew annual revenues in territory to more than US$ 4.5 million, particularly in service projects. - Increased profitability in territory by shifting revenue mix from low-profit products to high-margin services. - Exceeded KPIs every year.